# Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)

> **NCT07283575** · — · RECRUITING · sponsor: **Fudan University** · enrollment: 497 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer ctDNA Surveillance

## Interventions

- **DIAGNOSTIC_TEST:** Plasma ctDNA methylation profiling

## Key facts

- **NCT ID:** NCT07283575
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-10
- **Primary completion:** 2028-10-10
- **Final completion:** 2030-10-10
- **Target enrollment:** 497 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07283575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07283575, "Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07283575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*